{
    "title": "Roche's study flop marks yet another Alzheimer's setback",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10923645/Roches-study-flop-marks-Alzheimers-setback.html",
    "date": "2022-06-16",
    "keywords": [
        "drug",
        "crenezumab",
        "roche",
        "disease",
        "grover",
        "form",
        "thursday",
        "beta",
        "amyloid",
        "brain",
        "treatment",
        "research",
        "zurichlondon",
        "june",
        "decline",
        "risk",
        "drugmaker",
        "failure",
        "blow",
        "hypothesis",
        "protein",
        "plaque",
        "approach",
        "progression",
        "memoryrobbing",
        "study",
        "family",
        "columbia",
        "gene",
        "mutation",
        "placebo",
        "afternoon",
        "trading",
        "developer",
        "ac",
        "immune",
        "charge",
        "development",
        "licence",
        "agreement",
        "pair",
        "phase",
        "iii",
        "use",
        "field",
        "fatal",
        "profile",
        "adoption",
        "biogen",
        "inc",
        "health",
        "regulator",
        "light",
        "evidence",
        "benefit",
        "part",
        "lack",
        "dementia",
        "cancer",
        "setback",
        "latestage",
        "gantenerumab",
        "year",
        "company",
        "product",
        "everyone",
        "type",
        "chairman",
        "christoph",
        "franz",
        "month",
        "reporting",
        "silke",
        "koltrowitz",
        "zurich",
        "editing",
        "jacqueline",
        "wong",
        "edmund",
        "blair"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}